| Lipid profile in subclinical hypothyroidism: is L-thyroxine substitution beneficial? Z Efstathiadou, S Bitsis, HJ Milionis, A Kukuvitis, ET Bairaktari, MS Elisaf, ... European journal of endocrinology 145 (6), 705-710, 2001 | 255 | 2001 |
| Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia HJ Milionis, AI Kakafika, SG Tsouli, VG Athyros, ET Bairaktari, ... American heart journal 148 (4), 635-640, 2004 | 237 | 2004 |
| Atorvastatin preferentially reduces LDL-associated platelet-activating factor acetylhydrolase activity in dyslipidemias of type IIA and type IIB V Tsimihodimos, SAP Karabina, AP Tambaki, E Bairaktari, ... Arteriosclerosis, thrombosis, and vascular biology 22 (2), 306-311, 2002 | 218 | 2002 |
| Increased serum levels of interleukin-1β in the systemic circulation of patients with essential hypertension: additional risk factor for atherogenesis in hypertensive patients? GN Dalekos, M Elisaf, E Bairaktari, O Tsolas, KC Siamopoulos Journal of Laboratory and Clinical Medicine 129 (3), 300-308, 1997 | 198 | 1997 |
| Gender‐related and age‐related urinalysis of healthy subjects by NMR‐based metabonomics NG Psihogios, IF Gazi, MS Elisaf, KI Seferiadis, ET Bairaktari NMR in Biomedicine: An International Journal Devoted to the Development and …, 2008 | 196 | 2008 |
| Effect of letrozole on the lipid profile in postmenopausal women with breast cancer MS Elisaf, ET Bairaktari, C Nicolaides, B Kakaidi, CS Tzallas, A Katsaraki, ... European journal of cancer 37 (12), 1510-1513, 2001 | 179 | 2001 |
| Altered distribution of platelet-activating factor-acetylhydrolase activity between LDL and HDL as a function of the severity of hypercholesterolemia V Tsimihodimos, SAP Karabina, AP Tambaki, E Bairaktari, G Miltiadous, ... Journal of lipid research 43 (2), 256-263, 2002 | 165 | 2002 |
| Fenofibrate induces HDL-associated PAF-AH but attenuates enzyme activity associated with apoB-containing lipoproteins V Tsimihodimos, A Kakafika, AP Tambaki, E Bairaktari, MJ Chapman, ... Journal of lipid research 44 (5), 927-934, 2003 | 159 | 2003 |
| Effect of micronized fenofibrate and losartan combination on uric acid metabolism in hypertensive patients with hyperuricemia M Elisaf, V Tsimichodimos, E Bairaktari, KC Siamopoulos Journal of cardiovascular pharmacology 34 (1), 60-63, 1999 | 120 | 1999 |
| The incidence of thyroid function abnormalities in patients attending an outpatient lipid clinic V TSIMIHODIMOS, E BAIRAKTARI, C TZALLAS, G MILTIADUS, ... Thyroid 9 (4), 365-368, 1999 | 116 | 1999 |
| Risk factors for first-ever acute ischemic non-embolic stroke in elderly individuals HJ Milionis, E Liberopoulos, J Goudevenos, ET Bairaktari, K Seferiadis, ... International journal of Cardiology 99 (2), 269-275, 2005 | 114 | 2005 |
| Evaluation of methods for the measurement of low-density lipoprotein cholesterol ET Bairaktari, KI Seferiadis, MS Elisaf Journal of cardiovascular pharmacology and therapeutics 10 (1), 45-54, 2005 | 112 | 2005 |
| BRAF mutations, microsatellite instability status and cyclin D1 expression predict metastatic colorectal patients’ outcome Z Saridaki, D Papadatos-Pastos, M Tzardi, D Mavroudis, E Bairaktari, ... British journal of cancer 102 (12), 1762-1768, 2010 | 110 | 2010 |
| Hypomagnesemia and concurrent acid–base and electrolyte abnormalities in patients with congestive heart failure HJ Milionis, GE Alexandrides, EN Liberopoulos, ET Bairaktari, ... European journal of heart failure 4 (2), 167-173, 2002 | 109 | 2002 |
| The combination of nebivolol plus pravastatin is associated with a more beneficial metabolic profile compared to that of atenolol plus pravastatin in hypertensive patients with … E Rizos, E Bairaktari, A Kostoula, G Hasiotis, A Achimastos, E Ganotakis, ... Journal of cardiovascular pharmacology and therapeutics 8 (2), 127-134, 2003 | 108 | 2003 |
| Role of the spleen in lipid metabolism M Fatouros, K Bourantas, E Bairaktari, M Elisaf, O Tsolas, D Cassioumis Journal of British Surgery 82 (12), 1675-1677, 1995 | 105 | 1995 |
| Concentration and relative distribution of low-density lipoprotein subfractions in patients with metabolic syndrome defined according to the National Cholesterol Education … I Gazi, V Tsimihodimos, T Filippatos, E Bairaktari, AD Tselepis, M Elisaf Metabolism 55 (7), 885-891, 2006 | 104 | 2006 |
| Estimation of LDL cholesterol based on the Friedewald formula and on apo B levels E Bairaktari, K Hatzidimou, C Tzallas, M Vini, A Katsaraki, A Tselepis, ... Clinical biochemistry 33 (7), 549-555, 2000 | 104 | 2000 |
| Clinical and laboratory characteristics of hypernatraemia in an internal medicine clinic G Liamis, V Tsimihodimos, M Doumas, A Spyrou, E Bairaktari, M Elisaf Nephrology Dialysis Transplantation 23 (1), 136-143, 2008 | 102 | 2008 |
| Increased activity of platelet‐activating factor acetylhydrolase in low‐density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in … SAP Karabina, M Elisaf, E Bairaktari, C Tzallas, KC Siamopoulos, ... European journal of clinical investigation 27 (7), 595-602, 1997 | 94 | 1997 |
